Α-Pyrrolidinoheptaphenone

α-Pyrrolidinoheptaphenone
Clinical data
Other names	α-PHPP; alpha-PHPP; alpha-Pyrrolidinoheptiophenone; alpha-Pyrrolidinoheptanophenone; PV-8; PV8; Aphpp; A-PHPP
Legal status
Legal status	CA: Schedule I; DE: NpSG (Industrial and scientific use only); UK: Class B; US: Schedule I;
Identifiers
	IUPAC name 1-Phenyl-2-pyrrolidin-1-ylheptan-1-one;
CAS Number	13415-83-3 ; 13415-55-9 (HCl); 2304915-38-4 (R); 2304915-72-6 (S);
PubChem CID	69245534;
ChemSpider	57379805;
UNII	E6220IS097;
CompTox Dashboard (EPA)	DTXSID501016918 ;
Chemical and physical data
Formula	C17H25NO
Molar mass	259.393 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCCCCC(C(=O)C1=CC=CC=C1)N2CCCC2;
	InChI InChI=1S/C17H25NO/c1-2-3-5-12-16(18-13-8-9-14-18)17(19)15-10-6-4-7-11-15/h4,6-7,10-11,16H,2-3,5,8-9,12-14H2,1H3; Key:DLRWKNLMJAIFQB-UHFFFAOYSA-N;

α-Pyrrolidinoheptaphenone (PV8, α-PEP, α-PHPP, Aphpp, A-PHPP) is a designer drug of the pyrrolidinophenone class of cathinones.^[1]^[2] It is the higher homolog of α-pyrrolidinohexiophenone (α-PHP).

Quick facts Clinical data, Other names ...

In the United States, α-pyrrolidinoheptaphenone is a Schedule I Controlled Substance.^[3]

See also